Renalytix annual free cash flow
2019
2020
2021
2022
2023
2024
Renalytix Free Cash Flow (FCF) History (RNLXY)
Renalytix reported −$30.1M in free cash flow for fiscal 2024, an increase of $4.0M from the previous fiscal year, with a free cash flow margin of −1315.64%.
View full Renalytix company overviewRenalytix free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-06-30 | −$30.1M | $4.0M | — | −1315.64% |
| 2023 | 2023-06-30 | −$34.1M | $12.4M | — | −34085.00% |
| 2022 | 2022-06-30 | −$46.5M | −$17.3M | — | −1565.02% |
| 2021 | 2021-06-30 | −$29.2M | −$18.8M | — | −1956.54% |
| 2020 | 2020-06-30 | −$10.3M | −$3.9M | — | — |
| 2019 | 2019-06-30 | −$6.5M | — | — | — |
Renalytix quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Renalytix free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$6.5M to −$30.1M, a net decrease of $23.6M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Renalytix filings at SEC.gov ↗